IIM: Clinical Trials

3 trials for IIM, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 withdrawn. 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Recruiting 2, Withdrawn 1

Follow IIM: new trials by email Literature Review of IIM trials Research Report on IIM

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases.
RD06-05 CART Cell Injection - SLE, LN
Early Phase 1RecruitingNanjing Bioheng Biotech Co., Ltd.962025-07-242026-08-03
Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases
RD06-05 CART Cell Injection - SLE, Systemic Sclerosis
Early Phase 1RecruitingNanjing Bioheng Biotech Co., Ltd.182025-01-032026-02-02
A Study of RD06-04 in Patients With Active Autoimmune Diseases
RD06-04 cell infusion - SLE, Sclerosis
Early Phase 1WithdrawnNanjing Bioheng Biotech Co., Ltd.2024-08-312026-02-03

Narrower conditions

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (3)  ·  Anti-Glomerular Basement Membrane Disease (1)  ·  Glomerulonephritis, IGA (1)  ·  Neuromyelitis Optica (1)  ·  Scleroderma, Systemic (1)  ·  Sclerosis (1)

Broader conditions

Autoimmune Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Immune System Diseases (3)  ·  Skin Diseases (3)  ·  Skin Diseases, Vascular (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Systemic Vasculitis (3)  ·  Vascular Diseases (3)  ·  Vasculitis (3)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Connective Tissue Diseases (1)  ·  Cranial Nerve Diseases (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Eye Diseases (1)

Sponsors

Nanjing Bioheng Biotech Co., Ltd. (3)

Countries

China (3)